zurück zur Startseite
Zentrale Tel.: 06221-560
Molecular Medicine Partnership Unit

 

Members

More than 100 international researchers, physicians and technicians from five different university institutes and hospitals (Department of Pediatrics, Institute of Pathology, Institute of Microbiology, Department of Internal  Medicine and Institute of Pharmacology) and four different EMBL Units (3 in Heidelberg: Directors’ Research, Genome Biology and Structural and Computational Biology and 1 in Monterotondo: Mouse Biology) work in eight groups on important molecular medicine topics.

Opens internal link in current windowMembers: Diseases of mRNA metabolism
(Blood Diseases)
Group leaders: Andreas Kulozik and Matthias Hentze 

 

Opens internal link in current windowMembers: Molecular Pathogenesis of Colorectal Cancer and Development of Novel Approaches for Early Detection, Diagnosis and Prevention (Cancer Early Detection, Diagnosis and Prevention CED-DAP)
(Cancer Early Detection)
Group leaders: Magnus von Knebel Doeberitz and Peer Bork

 

Opens internal link in current windowMembers: Molecular mediators of chronic pain
(Chronic Pain)
Group Leaders: Rohini Kuner, Jan Siemens and Paul Heppenstall

 

Opens internal link in current windowMembers: Interfering with assembly and maturation of infectious HIV-1
(HIV-1 fomation and its inhibitiion)
Group Leaders: Hans-Georg Kräusslich and John A.G. Briggs

 

Opens internal link in current windowMembers: Iron homeostasis in health and disease
(Iron Homeostasis)
Group leaders: Martina Muckenthaler and Matthias Hentze

 

Opens internal link in current windowMembers: Molecular Pediatric Oncology
(Molecular Pediatric Oncology)
Group Leaders: Andreas Kulozik and Jan Korbel

 

 Opens internal link in current windowMembers: Stem Cell–Niche Networks in Ageing and Disease
(Stem Cell-Niche Networks)
Group Leaders: Caroline Pabst, Anthony D. Ho, Carsten Müller–Tidow and Anne–Claude Gavin, Judith Zaugg

 

Opens internal link in current windowMembers: Systems Medicine of Cancer Drugs
(Systems Medicine of Cancer Drugs)
Group Leaders: Sascha Dietrich and Wolfgang Huber

Print Diese Seite per E-Mail weiterempfehlen